您当前所在的位置:首页 > 产品中心 > 产品信息
Lomerizine dihydrochloride_分子结构_CAS_101477-54-7)
点击图片或这里关闭

Lomerizine dihydrochloride

产品号 L6295 公司名称 Sigma Aldrich
CAS号 101477-54-7 公司网站 http://www.sigmaaldrich.com
分子式 C27H32Cl2F2N2O3 电 话 1-800-521-8956
分子量 541.4573864 传 真
纯 度 ≥98% (HPLC) 电子邮件
保 存 Chembase数据库ID: 154901

产品价格信息

请登录

产品别名

标题
Lomerizine dihydrochloride
IUPAC标准名
1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride
IUPAC传统名
lomerizine dihydrochloride
别名
1-[Bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride

产品登记号

MDL号 MFCD01703867
CAS号 101477-54-7

产品性质

Empirical Formula (Hill Notation) C27H30F2N2O3·2HCl
纯度 ≥98% (HPLC)
外观 white to tan powder
溶解度 DMSO: ≥30 mg/mL
GHS危险品标识 GHS07
GHS危险品标识 GHS09
GHS警示词 Warning
GHS危险声明 H302-H410
欧盟危险性物质标志 有害性(Harmful) 有害性(Harmful) (Xn)
欧盟危险性物质标志 环境危害性(Nature polluting) 环境危害性(Nature polluting) (N)
MSDS下载 下载链接
GHS警示性声明 P273-P501
危险公开号 22-50
RTECS编号 TK9189000
安全公开号 61
保存温度 2-8°C
德国WGK号 3

产品详细信息

详细说明 (English)
Biochem/physiol Actions
Lomerizine dihydrochloride is a voltage-dependent calcium channel blocker and selective cerebral vasodilator. It is one of the most selective calcium channel blockers for the CNS and cerebral arteries. It has been reported to inhibit both T-type and L-type Ca2+ currents in rat hippocampal CA1 pyramidal neurons, to prevent glutamate-induced neurotoxicity in rat hippocampal primary cell cultures, and to exhibit protective effects in animal models of migraine, ischemia and hypoxia. In Japan, lomerizine has been used as the first-line prophylactic drug for migraines.
详细说明 (简体中文)
Biochem/physiol Actions
Lomerizine dihydrochloride is a voltage-dependent calcium channel blocker and selective cerebral vasodilator. It is one of the most selective calcium channel blockers for the CNS and cerebral arteries. It has been reported to inhibit both T-type and L-type Ca2+ currents in rat hippocampal CA1 pyramidal neurons, to prevent glutamate-induced neurotoxicity in rat hippocampal primary cell cultures, and to exhibit protective effects in animal models of migraine, ischemia and hypoxia. In Japan, lomerizine has been used as the first-line prophylactic drug for migraines.

参考文献